About Us
At a Glance
Careers
Management Team
Board of Directors
Target Markets
HCV Overview
Anti-Bacterial Overview
Product Pipeline
Sovaprevir (ACH-1625)
ACH-2684
ACH-3102
ACH-3422
ACH-702
Elvucitabine
Discovery Programs
Discovery Technologies
News Center
Press Releases
Calendar
Resources
Investors
Corporate Information
Company News
Financial Information
Stock Information
Shareholder Services
Home
About Us
At a Glance
Careers
Management Team
Board of Directors
Target Markets
HCV Overview
Introduction to Viruses and HCV
HCV Market Challenges
HCV Market Opportunity
Anti-Bacterial Overview
Product Pipeline
Sovaprevir (ACH-1625)
Sovaprevir Data Overview
Sovaprevir Program Overview
ACH-2684
ACH-3102
ACH-3422
ACH-702
Elvucitabine
Discovery Programs
Discovery Technologies
News Center
Press Releases
Calendar
Resources
Investors
Corporate Information
Company News
Financial Information
Stock Information
Shareholder Services
© Copyright 2013 Achillion Pharmaceuticals, Inc. All rights reserved. Page Last Updated Oct 25, 2011
